The Sciences
Health
Environment
Aerospace
Education
Facebook
Twitter
The Sciences
Health
Environment
Aerospace
Education
The Sciences
Health
Environment
Aerospace
Education
aducanumab
Studying the Genes That Delay Alzheimer’s Decline May Lead to Treatments
New Alzheimer’s Drugs Don’t Deserve the Hype – Here’s Why
As US FDA Approves New Drug for Alzheimer’s, Scientists Flag Safety Concerns
What Explains the FDA’s Big Gamble on Aducanumab, the New Alzheimer’s Drug?
Mixed Results From Trial, but FDA Approval for Alzheimer Drug Hailed as Victory
Scroll To Top